Unicorn Nest Logo

Tao Capital

Total investments

16

Average round size

42M

Portfolio companies

15

Rounds per year

1.60

Lead investments

1

Follow on index

0.06

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalPharmaceuticalEnergyOil and GasProduct ResearchEnergy Management

Investments analytics

Analytics

Total investments
16
Lead investments
1
Rounds per year
1.60
Follow on index
0.06
Investments by industry
  • Biotechnology (8)
  • Health Care (7)
  • Pharmaceutical (4)
  • Medical (3)
  • Medical Device (2)
    • Show 13 more
Investments by region
  • United States (2)
  • China (13)
Peak activity year
2022
Number of Unicorns
2
Number of Decacorns
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
201M
Group Appearance index
0.94

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Crusoe Energy Systems 21 Apr 2022 Energy, Oil and Gas, Energy Management Late Stage Venture 350M United States, Colorado, Denver
Rhino Medical 27 Dec 2023 Medical, Pharmaceutical, Intellectual Property, Product Research Early Stage Venture 15M
Seekr 30 Dec 2014 Information Technology, Enterprise Software, Social Media Early Stage Venture 760K São Paulo, São Paulo, Brazil
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.